Indefinite Delivery Contract 36C24E20D0027

Award Date 8/19/20
Last Date to Order 12/31/20
Awardee
Vitalant
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
Coronavirus COVID-19
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Vitalant, a nonprofit organization, to provide therapeutic apheresis treatments, blood, plasma, and other blood products to support veteran patients. The contract has a ceiling value of $289,066.90 and a performance period ending on July 14, 2028. Under this IDC, the VA has issued two delivery orders to Vitalant's research division, Vitalant Research Institute (VRI), for a total ceiling value of $99,630....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a single award indefinite delivery contract to Vitalant Research Institute for the provision of blood products. Under the base contract valued at $276,281.56, Vitalant Research Institute has been issued three firm fixed price delivery orders to date for a combined value of $221,016.27. The delivery orders issued against the contract on August 1, 2021 for $90,646.50, August 1, 2022...
Vitalant Research Institute was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration to provide blood and blood products. The single award IDV has a potential value of $1,097,215 and period of performance through September 2025. Three firm fixed price delivery orders have been placed against this vehicle to date for a combined value of $470,567.31. The orders require Vitalant to supply blood and blood products to the Fargo Veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a single-award Indefinite Delivery Contract with a potential value of $1,300,000 to Vitalant for the delivery of blood and blood products. The award includes a base period of performance from December 2020 through November 2025. The contract was established to fulfill requirements outlined in a November 2020 pre-solicitation notice seeking quotes for blood and blood products to...
The Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) has awarded a sole source, firm-fixed-price, Indefinite Delivery-Indefinite Quantity (IDIQ) contract to Vitalant, a nonprofit blood services provider, for the provision of human blood and blood-related products. The five-year contract, valued at up to $600,000, will support the VA Northern California Healthcare System. The contract includes five one-year ordering periods from October 1, 2024, to September 30, 2029,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) awarded a single-award indefinite delivery contract to Vitalant VRI - Vitalant Research Institute Division, doing business as Vitalant Research Institute, to provide blood and blood products to the Mather Medical Center in Mather, California. The base contract has a ceiling value of $6.5 million and a period of performance from October 1, 2022 to September 30, 2027. Under this IDC, Vitalant has received...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 (VA-VHA) awarded a single-award Blanket Purchase Agreement (BPA) Call contract to Vitalant Research Institute (VRI) valued at approximately $716,702. The contract provides blood products to support VA-VHA healthcare programs for veterans from November 19, 2022 through September 30, 2025. Performance will take place in Scottsdale, Arizona. The BPA establishes a fixed-price agreement for VRI...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a single award blanket purchase agreement to Vitalant Research Institute for the provision of human blood and blood products. The potential value of this IDV is $4.9M with a period of performance through September 2028. A task order was issued against this IDV valued at approximately $979K for the supply of human blood and blood products to the Rocky Mountain Regional Medical...
The Defense Health Agency awarded a blanket purchase agreement to Blood Centers of America, Inc. for the delivery of COVID-19 convalescent plasma. Under the single award agreement and associated task orders, Blood Centers of America will provide convalescent plasma valued at $8.789 million to support the Department of Defense's response to the COVID-19 pandemic. Performance will take place at Blood Centers of America's facility in Mosby, Virginia through November 30, 2021. The task orders...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA-VHA) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract valued at up to $6,000,000 to Vitalant VRI, the research division of Vitalant, a nonprofit blood collection and services provider. The IDIQ contract is for the provision of blood and blood products to support the VA's San Francisco Veterans Affairs Medical Center. Vitalant VRI has previously held several IDIQ...
  • 36C24E20D0027
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration awarded a single award, firm fixed price Indefinite Delivery Contract to Vitalant Research Institute of Scottsdale, Arizona. The contract has a potential value of $1,679,700 to support the agency's Coronavirus COVID-19 national interest efforts through August 2021. Under the original solicitation, Vitalant will provide up to 1,200 units of 200mL bags of COVID-19 Convalescent Plasma for a 24-month VA clinical study to treat COVID-19 patients. The plasma must meet all FDA and ISBT 128 labeling guidelines.

A subsequent $1,679,700 delivery order was issued for Vitalant to provide COVID-19 Convalescent Plasma and support the VA clinical research study through August 2021. As the prime contractor, Vitalant will perform all work in Scottsdale, Arizona. The funding agency, Veterans Health Administration Veterans Integrated Service Network 22, aims to research potential treatment applications of plasma from recovered COVID-19 patients to support veterans integrated healthcare services across parts of multiple western states. Vitalant as the sole source contractor is uniquely qualified to meet all technical requirements for standardized plasma products and national distribution scope to enable the clinical trial objectives of the Veterans Health Administration.

Generated 1/4/24, 11:57 PM